Oracle Corporation (NYSE: ORCL) saw its stock rise 2.2% in after-hours trading on Monday, despite missing Wall Street expectations in its fiscal Q3 results.
For the quarter ending Feb. 28, Oracle reported adjusted earnings per share (EPS) of $1.47 on revenue of $14.13 billion, falling short of analyst estimates of $1.49 EPS and $14.39 billion in revenue. However, the tech giant’s strong order book fueled investor optimism.
CEO Safra Catz highlighted that Oracle’s $130 billion sales backlog is expected to drive a 15% revenue increase in fiscal 2026. She also noted the company’s growing remaining performance obligations (RPO), which surged 62% to $130 billion. Additionally, Oracle anticipates significant expansion in its AI training and inferencing businesses, particularly with its upcoming Stargate contract.
Chairman and CTO Larry Ellison emphasized record customer demand, stating that Oracle remains on track to double its data center capacity this year.
In a move to boost shareholder value, Oracle increased its quarterly dividend by 25% to $0.50 per share, or $2.00 annually, up from $1.60.
Analysts offered mixed reactions. Jefferies' Brent Thill described the results as “mixed,” noting that while backlog and capital expenditures exceeded expectations, IaaS and SaaS growth fell slightly below forecasts. Evercore ISI’s Kirk Materne pointed out the revenue and EPS miss but highlighted the “massive jump” in RPO, which doesn’t yet factor in the anticipated Stargate deal.
Despite the earnings shortfall, Oracle’s strong backlog and AI-driven growth plans suggest promising long-term potential, keeping investors engaged.


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Judge Dismisses Sam Altman Sexual Abuse Lawsuit, But Sister Can Refile
California's AI Executive Order Pushes Responsible Tech Use in State Contracts
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Golden Dome Missile Defense: Anduril and Palantir Join Forces on Trump's $185B Space Shield
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
OpenAI's Desktop Superapp: Unifying ChatGPT, Codex, and Browser Tools for Enterprise AI
Makemation: a Nollywood movie that shows AI in action in Africa
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push 



